Cargando…
Use of the directional atherectomy for the treatment of femoro-popliteal lesions in patients with critical lower limb ischemia
Femoro-popliteal PTA for the treatment of critical limb ischemia is frequently associated with unsatisfactory procedural success rates while directional atherectomy (DCA) has improved success rate since claudicant patients undergoing percutaneous treatment of femoro-popliteal obstructive disease. Th...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università di Salerno
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120749/ https://www.ncbi.nlm.nih.gov/pubmed/27896226 |
_version_ | 1782469290161602560 |
---|---|
author | Bracale, Umberto Marcello Vitale, Gaetano Bajardi, Guido Narese, Donatella Dinoto, Ettore Giribono, Anna Maria Ferrara, Doriana del Guercio, Luca Midiri, Massimo Pecoraro, Felice |
author_facet | Bracale, Umberto Marcello Vitale, Gaetano Bajardi, Guido Narese, Donatella Dinoto, Ettore Giribono, Anna Maria Ferrara, Doriana del Guercio, Luca Midiri, Massimo Pecoraro, Felice |
author_sort | Bracale, Umberto Marcello |
collection | PubMed |
description | Femoro-popliteal PTA for the treatment of critical limb ischemia is frequently associated with unsatisfactory procedural success rates while directional atherectomy (DCA) has improved success rate since claudicant patients undergoing percutaneous treatment of femoro-popliteal obstructive disease. The aim of this prospective study is to evaluate the safety, efficacy and procedural success of DCA, at one year, in the percutaneous treatment of femoro-popliteal obstructive disease in patients with critical limb ischemia. METHODS: From March 2012 to March 2013 18 consecutive patients with critical limb ischemia were treated with DCA (Turbohawk/Covidien-ev3 Endovascular Inc., North Plymouth, Minnesota, USA) for the treatment of femoro-popliteal obstructive disease. Patients were evaluated at 12 months. RESULTS: Technical and procedural success was achieved in every patient. No in-hospital major adverse cardiovascular events occurred. Primary endpoint: freedom from any amputation was obtained in all patients. Secondary endpoints: clinical (Rutherford class improvement) and hemodynamic success (Ankle-brachial index improvement) was achieved in all patients. CONCLUSION: The use of DCA for the treatment of femoro-popliteal obstructive disease is a safe and effective therapeutic strategy for patients with critical limb ischemia. The data included in our study should be considered hypothesis-generating in order to design of a randomized trial comparison with conventional PTA. |
format | Online Article Text |
id | pubmed-5120749 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Università di Salerno |
record_format | MEDLINE/PubMed |
spelling | pubmed-51207492016-11-28 Use of the directional atherectomy for the treatment of femoro-popliteal lesions in patients with critical lower limb ischemia Bracale, Umberto Marcello Vitale, Gaetano Bajardi, Guido Narese, Donatella Dinoto, Ettore Giribono, Anna Maria Ferrara, Doriana del Guercio, Luca Midiri, Massimo Pecoraro, Felice Transl Med UniSa Articles Femoro-popliteal PTA for the treatment of critical limb ischemia is frequently associated with unsatisfactory procedural success rates while directional atherectomy (DCA) has improved success rate since claudicant patients undergoing percutaneous treatment of femoro-popliteal obstructive disease. The aim of this prospective study is to evaluate the safety, efficacy and procedural success of DCA, at one year, in the percutaneous treatment of femoro-popliteal obstructive disease in patients with critical limb ischemia. METHODS: From March 2012 to March 2013 18 consecutive patients with critical limb ischemia were treated with DCA (Turbohawk/Covidien-ev3 Endovascular Inc., North Plymouth, Minnesota, USA) for the treatment of femoro-popliteal obstructive disease. Patients were evaluated at 12 months. RESULTS: Technical and procedural success was achieved in every patient. No in-hospital major adverse cardiovascular events occurred. Primary endpoint: freedom from any amputation was obtained in all patients. Secondary endpoints: clinical (Rutherford class improvement) and hemodynamic success (Ankle-brachial index improvement) was achieved in all patients. CONCLUSION: The use of DCA for the treatment of femoro-popliteal obstructive disease is a safe and effective therapeutic strategy for patients with critical limb ischemia. The data included in our study should be considered hypothesis-generating in order to design of a randomized trial comparison with conventional PTA. Università di Salerno 2016-11-01 /pmc/articles/PMC5120749/ /pubmed/27896226 Text en http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Articles Bracale, Umberto Marcello Vitale, Gaetano Bajardi, Guido Narese, Donatella Dinoto, Ettore Giribono, Anna Maria Ferrara, Doriana del Guercio, Luca Midiri, Massimo Pecoraro, Felice Use of the directional atherectomy for the treatment of femoro-popliteal lesions in patients with critical lower limb ischemia |
title | Use of the directional atherectomy for the treatment of femoro-popliteal lesions in patients with critical lower limb ischemia |
title_full | Use of the directional atherectomy for the treatment of femoro-popliteal lesions in patients with critical lower limb ischemia |
title_fullStr | Use of the directional atherectomy for the treatment of femoro-popliteal lesions in patients with critical lower limb ischemia |
title_full_unstemmed | Use of the directional atherectomy for the treatment of femoro-popliteal lesions in patients with critical lower limb ischemia |
title_short | Use of the directional atherectomy for the treatment of femoro-popliteal lesions in patients with critical lower limb ischemia |
title_sort | use of the directional atherectomy for the treatment of femoro-popliteal lesions in patients with critical lower limb ischemia |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120749/ https://www.ncbi.nlm.nih.gov/pubmed/27896226 |
work_keys_str_mv | AT bracaleumbertomarcello useofthedirectionalatherectomyforthetreatmentoffemoropopliteallesionsinpatientswithcriticallowerlimbischemia AT vitalegaetano useofthedirectionalatherectomyforthetreatmentoffemoropopliteallesionsinpatientswithcriticallowerlimbischemia AT bajardiguido useofthedirectionalatherectomyforthetreatmentoffemoropopliteallesionsinpatientswithcriticallowerlimbischemia AT naresedonatella useofthedirectionalatherectomyforthetreatmentoffemoropopliteallesionsinpatientswithcriticallowerlimbischemia AT dinotoettore useofthedirectionalatherectomyforthetreatmentoffemoropopliteallesionsinpatientswithcriticallowerlimbischemia AT giribonoannamaria useofthedirectionalatherectomyforthetreatmentoffemoropopliteallesionsinpatientswithcriticallowerlimbischemia AT ferraradoriana useofthedirectionalatherectomyforthetreatmentoffemoropopliteallesionsinpatientswithcriticallowerlimbischemia AT delguercioluca useofthedirectionalatherectomyforthetreatmentoffemoropopliteallesionsinpatientswithcriticallowerlimbischemia AT midirimassimo useofthedirectionalatherectomyforthetreatmentoffemoropopliteallesionsinpatientswithcriticallowerlimbischemia AT pecorarofelice useofthedirectionalatherectomyforthetreatmentoffemoropopliteallesionsinpatientswithcriticallowerlimbischemia |